Ryoji Yoshida

2.3k total citations
77 papers, 1.6k citations indexed

About

Ryoji Yoshida is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Ryoji Yoshida has authored 77 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 29 papers in Molecular Biology and 21 papers in Cancer Research. Recurrent topics in Ryoji Yoshida's work include Head and Neck Cancer Studies (17 papers), Cancer-related molecular mechanisms research (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Ryoji Yoshida is often cited by papers focused on Head and Neck Cancer Studies (17 papers), Cancer-related molecular mechanisms research (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Ryoji Yoshida collaborates with scholars based in Japan, Egypt and United States. Ryoji Yoshida's co-authors include Hideki Nakayama, Masanori Shinohara, Masashi Nagata, Kenta Kawahara, Takaaki Ito, Akiyuki Hirosue, Wael Abdo Hassan, Akimitsu Hiraki, Kanako Niimori‐Kita and Junki Sakata and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ryoji Yoshida

71 papers receiving 1.5k citations

Peers

Ryoji Yoshida
Trine Tramm Denmark
Ryoji Yoshida
Citations per year, relative to Ryoji Yoshida Ryoji Yoshida (= 1×) peers Trine Tramm

Countries citing papers authored by Ryoji Yoshida

Since Specialization
Citations

This map shows the geographic impact of Ryoji Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryoji Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryoji Yoshida more than expected).

Fields of papers citing papers by Ryoji Yoshida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryoji Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryoji Yoshida. The network helps show where Ryoji Yoshida may publish in the future.

Co-authorship network of co-authors of Ryoji Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of Ryoji Yoshida. A scholar is included among the top collaborators of Ryoji Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryoji Yoshida. Ryoji Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yano, Hiromu, Yoshihiro Komohara, Rin Yamada, et al.. (2025). Cytotoxic T Lymphocyte Density and PD‐L1 Expression Predict the Response to Anti‐PD1 Therapy in Recurrent Oral Squamous Cell Carcinoma. Microbiology and Immunology. 69(6). 350–358.
3.
Toya, Ryo, Tetsuo Saito, Tomohiko Matsuyama, et al.. (2024). Radiation Therapy Oncology Group 8502 “QUAD shot” regimen using volumetric modulated arc therapy for incurable head and neck cancer. Oral Oncology. 151. 106752–106752. 1 indexed citations
4.
Motoshima, Takanobu, Junji Yatsuda, Yoji Murakami, et al.. (2023). Sicca syndrome during ipilimumab and nivolumab therapy for metastatic renal cell carcinoma. IJU Case Reports. 6(2). 147–149. 2 indexed citations
5.
Shinriki, Satoru, Yutaka Nakachi, Yukio Fujiwara, et al.. (2021). Colonization of distant organs by tumor cells generating circulating homotypic clusters adaptive to fluid shear stress. Scientific Reports. 11(1). 6150–6150. 24 indexed citations
6.
Sakata, Junki, Akiyuki Hirosue, Ryoji Yoshida, et al.. (2020). Enhanced Expression of IGFBP-3 Reduces Radiosensitivity and Is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma. Cancers. 12(2). 494–494. 8 indexed citations
7.
Yoshida, Ryoji, Masashi Nagata, Akiyuki Hirosue, et al.. (2020). Efficacy of adjuvant chemotherapy with S-1 in stage II oral squamous cell carcinoma patients: A comparative study using the propensity score matching method. PLoS ONE. 15(4). e0231656–e0231656. 2 indexed citations
8.
Kawahara, Kenta, Akimitsu Hiraki, Hidetaka Arita, et al.. (2020). Role of serum amylase and salivary cytokines in oral complications during chemoradiotherapy. Oral Diseases. 27(6). 1564–1571. 5 indexed citations
9.
Yamamoto, Tatsuro, Akiyuki Hirosue, Ryoji Yoshida, et al.. (2020). BRD4 promotes metastatic potential in oral squamous cell carcinoma through the epigenetic regulation of the MMP2 gene. British Journal of Cancer. 123(4). 580–590. 24 indexed citations
10.
Yoshida, Ryoji, Junki Sakata, Yuichiro Matsuoka, et al.. (2020). Onodera's prognostic nutritional index correlates with tumor immune environment and survival in patients with oral squamous cell carcinoma undergoing chemoradiotherapy. Translational Oncology. 13(12). 100850–100850. 22 indexed citations
11.
Sakata, Junki, Akiyuki Hirosue, Ryoji Yoshida, et al.. (2019). HMGA2 Contributes to Distant Metastasis and Poor Prognosis by Promoting Angiogenesis in Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences. 20(10). 2473–2473. 34 indexed citations
12.
Kawahara, Kenta, Akimitsu Hiraki, Ryoji Yoshida, et al.. (2017). Salivary duct carcinoma treated with cetuximab-based targeted therapy: A case report. Molecular and Clinical Oncology. 6(6). 886–892. 10 indexed citations
13.
Hassan, Wael Abdo, Ryoji Yoshida, Shinji Kudoh, Yamato Motooka, & Takaaki Ito. (2016). Evaluation of role of Notch3 signaling pathway in human lung cancer cells. Journal of Cancer Research and Clinical Oncology. 142(5). 981–993. 40 indexed citations
14.
Yoshitake, Yoshihiro, Daiki Fukuma, Akira Yuno, et al.. (2014). Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS. Clinical Cancer Research. 21(2). 312–321. 123 indexed citations
15.
Nagata, Masashi, Yoshihiro Yoshitake, Hideki Nakayama, et al.. (2014). Angiosarcoma of the oral cavity: a clinicopathological study and a review of the literature. International Journal of Oral and Maxillofacial Surgery. 43(8). 917–923. 19 indexed citations
16.
Hassan, Wael Abdo, Ryoji Yoshida, Shinji Kudoh, et al.. (2014). Notch1 controls cell invasion and metastasis in small cell lung carcinoma cell lines. Lung Cancer. 86(3). 304–310. 53 indexed citations
17.
Suzuki, C., et al.. (2013). Analysis of Workpiece Behavior and Optimization of the Machining Conditions in Milling of a Long Shaft (1st Report). Journal of the Japan Society for Precision Engineering. 79(8). 784–789. 1 indexed citations
18.
Tanaka, Takuya, Hideki Nakayama, Yoshihiro Yoshitake, et al.. (2011). Selective inhibition of nuclear factor‐κB by nuclear factor‐κB essential modulator‐binding domain peptide suppresses the metastasis of highly metastatic oral squamous cell carcinoma. Cancer Science. 103(3). 455–463. 23 indexed citations
19.
Yoshida, Ryoji, Tetsuhiro Fujimoto, Shinji Kudoh, et al.. (2011). Nucleostemin affects the proliferation but not differentiation of oral squamous cell carcinoma cells. Cancer Science. 102(7). 1418–1423. 15 indexed citations
20.
Yoshida, Ryoji, et al.. (2010). A case of septic pulmonary embolism caused by odontogenic infection. Japanese Journal of Oral & Maxillofacial Surgery. 56(1). 49–53. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026